discount rate
How PacBio (PACB) Is Seeing Its Fair Value Story Change After ARK’s Share Purchase
admin
Analysts lifted their fair value estimate for California-based Pacific Biosciences from US$2.36 to US$2.50, which rested on a small set ...
How recent analyst upgrades are rewriting the growth story for Pampa Energía
admin
Pampa Energía’s latest research update kept the fair value estimate stable at ARS 5,016.5 per share and the discount rate ...
